Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sensus Healthcare Inc (SRTS)

Sensus Healthcare Inc (SRTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 64,057
  • Shares Outstanding, K 16,425
  • Annual Sales, $ 41,810 K
  • Annual Income, $ 6,650 K
  • EBIT $ -5 M
  • EBITDA $ -5 M
  • 60-Month Beta 1.24
  • Price/Sales 1.58
  • Price/Cash Flow 9.31
  • Price/Book 1.29

Options Overview Details

View History
  • Implied Volatility 347.30% (+165.48%)
  • Historical Volatility 81.62%
  • IV Percentile 95%
  • IV Rank 60.32%
  • IV High 567.02% on 11/21/25
  • IV Low 13.22% on 09/08/25
  • Expected Move (DTE 11) 0.62 (15.91%)
  • Put/Call Vol Ratio 0.23
  • Today's Volume 215
  • Volume Avg (30-Day) 93
  • Put/Call OI Ratio 0.70
  • Today's Open Interest 1,666
  • Open Int (30-Day) 2,323
  • Expected Range 3.28 to 4.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.09
  • Growth Rate Est. (year over year) +1,109,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.39 +15.04%
on 11/06/25
4.69 -16.84%
on 11/13/25
+0.21 (+5.69%)
since 11/05/25
3-Month
3.03 +28.63%
on 09/22/25
4.69 -16.84%
on 11/13/25
+0.67 (+20.74%)
since 09/05/25
52-Week
3.03 +28.71%
on 08/12/25
9.30 -58.09%
on 12/06/24
-5.00 (-56.18%)
since 12/05/24

Most Recent Stories

More News
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer

New responsibilities recognize Mr. Sardano’s significant accomplishments in securing CPT ® codes for office-based SRT and the growing commercial opportunity the Company now faces...

SRTS : 3.90 (-2.99%)
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors

Seasoned financial executive brings leadership acumen, strategic growth expertise and a strong track record of operational excellence

SRTS : 3.90 (-2.99%)
Sensus Healthcare Reports Third Quarter 2025 Financial Results

Centers for Medicare & Medicaid Services (CMS) established coding validating superficial radiotherapy (SRT) for treating non-melanoma skin cancer Revenues of $6.9 million ...

SRTS : 3.90 (-2.99%)
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026

Recognition in top 100 of this inaugural ranking of 500 companies reflects five-year growth performance, financial stability and stock performance

SRTS : 3.90 (-2.99%)
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer

First-ever dedicated Current Procedural Terminology (CPT®) codes represent compelling economics and reimbursement certainty

SRTS : 3.90 (-2.99%)
Sensus Healthcare Announces the Passing of Director Bill McCall

Sensus Healthcare, Inc. (Nasdaq: SRTS) , a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...

SRTS : 3.90 (-2.99%)
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...

SRTS : 3.90 (-2.99%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

NEW YORK , Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors...

SRTS : 3.90 (-2.99%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors...

SRTS : 3.90 (-2.99%)
Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids

Sensus Healthcare, Inc. (Nasdaq: SRTS) , a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...

SRTS : 3.90 (-2.99%)

Business Summary

Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare,...

See More

Key Turning Points

3rd Resistance Point 4.17
2nd Resistance Point 4.10
1st Resistance Point 4.00
Last Price 3.90
1st Support Level 3.83
2nd Support Level 3.76
3rd Support Level 3.66

See More

52-Week High 9.30
Fibonacci 61.8% 6.91
Fibonacci 50% 6.17
Fibonacci 38.2% 5.43
Last Price 3.90
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar